| Abstrakt: |
A study conducted by researchers at Cedars Sinai Medical Center in Los Angeles examined the relationship between liver diseases and metabolic dysfunction-associated steatotic liver disease (MASLD). The study found that hepatic steatosis in MASLD did not significantly increase the risk of mortality in individuals with any cardio-metabolic risk factor (CMRF). However, the study did find that the presence of metabolic alcoholic liver disease (MetALD) was associated with increased all-cause, cancer, and liver mortality risk. The researchers concluded that controlling metabolic risk factors and reducing alcohol consumption are crucial for improving long-term health outcomes in individuals with MASLD or MetALD. [Extracted from the article] |
